SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors 24-month HOPE-3 extension data showing slower upper-limb decline among Duchenne muscular dystrophy patients treated with deramiocel is driving attention ahead of the FDAs review. Traders largely view the results as supportive of approval and anticipate short-covering, while skeptics caution that the open-label data may not resolve the FDAs concerns.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings selection to develop the Navys next-generation F/A-XX fighter is driving attention, with traders highlighting the multibillion-dollar award and its potential to strengthen the defense business alongside the Air Forces F-47 program. Many view the win as a positive counterweight to commercial-program challenges, though others question whether Boeing can execute reliably across its growing workload.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances higher full-year revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, sparked a sharp rally and drew attention to analyst upgrades. Traders are broadly bullish, while debate centers on profit-taking and possible dilution; short-squeeze talk and hopes for future lung-cancer data remain speculative.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

The FHFAs move to let VantageScore compete alongside FICO in mortgage underwriting has investors questioning FICOs pricing power and long-standing position in the market. Traders are divided between seeing a lasting threat to its competitive moat and viewing the selloff as an overreaction, since lender adoption and the impact on FICOs business remain uncertain.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vandas positive Phase 3 results for Hetlioz in delayed sleep-wake phase disorder are driving attention; the trial met its primary endpoint, and the company plans to discuss the data with the FDA before pursuing an expanded indication. Traders are largely upbeat about the potential new use, though some caution that approval and commercial impact remain uncertain, alongside speculative buyout talk.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWM is drawing attention for persistent small-cap underperformance as rising Treasury yields and expectations of further Fed tightening weigh on rate-sensitive, debt-heavy companies, while mega-cap tech remains comparatively resilient. Traders are split between expecting more downside and seeing oversold conditions near support as a potential base; a recovery case generally depends on yields easing.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts Copilot overhaul, adding Office integration, coding tools and autonomous agents, is the main catalyst behind the stocks rally and breakout chatter. Bulls see stronger enterprise AI adoption and monetization potential, while skeptics question whether the features will gain traction or justify the heavy AI investment.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphases IQ Solid State Transformer initiative for AI data centers is drawing attention, with traders pointing to U.S. production progress and planned demonstrations and customer pilots as a possible new growth avenue. Bulls see squeeze potential, while skeptics note that the opportunity is still developing and residential solar demand remains pressured by rates and policy uncertainty.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

Fervos Cape Station geothermal project has reached first power and is exporting electricity to the grid, a milestone traders view as validation of its path from pilot projects to utility-scale generation. Reactions are split: some see reduced execution risk and a boost to the AI data-center power story, while others point to the stocks weak reaction, high capital needs, and risk of further financing or delays.

Pasqal Holding SA engages in the builds and delivers industry-ready neutral-atom QPUs, which believe are designed to transform cutting-edge scientific breakthroughs into real-world business solutions across multiple industries. The company is headquarter in Palaiseau, France.

Pasqal Holding SA

Pasqals sharp post-SPAC selloff is drawing attention, with bearish traders citing dilution, its financial structure and uncertainty around the companys strategic direction. Others view the decline as an opportunity, pointing to its commercial partnerships and European quantum-computing prospects, while some speculate that the tight float could amplify a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Stockman34

Bob Feldman